Delivery Order SPE2DB22D3016-SPE2DB25FBEA8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,678.37 to AmerisourceBergen Drug Corp for Difici 200 mg tablets (20-count) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price, non-set-aside contract was awarded competitively and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The order represents a small-value transaction within the company's broader pharmaceutical supply relationship with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DIFICID 200 MG TABLET 20S. The contract has a firm fixed price of $43,570.45 and a period of performance through April 16, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for federal...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide DIFICID 200 mg tablets. The contract has a completion date of February 6, 2024 and a potential value of $3,631.01. This delivery order is likely part of a larger indefinite delivery contract (IDC) that AmerisourceBergen Drug Corp holds with DLA Troop Support Medical, with a potential value of up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,057.29 firm-fixed-price delivery order is for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of December 24, 2024 and was awarded on December 23, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,578.55 firm fixed-price delivery order is for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a firm fixed-price delivery order for $11,859.53 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the drug DIFICID 200 MG TABLET 20S, with a performance period ending on February 14, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $30,906.26, is for the delivery of DIFICID 200 mg tablets over the period of performance ending on April 29, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of DIFICID 200 MG TABLET 20S. The $27,970.07 order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for AmerisourceBergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,249,121 units of DIFICID 200 MG TABLET 20S. The $8,831.37 contract has an ultimate completion date of April 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through...
- This is a $5,411.74 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 200 mg DIFICID tablets. It has an ultimate completion date of July 10, 2025 and is not set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBEA8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,425.54 to AmerisourceBergen Drug Corp for 20 tablets of Difici 200 mg on August 5, 2025, with an ultimate completion date of August 6, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award leverages AmerisourceBergen's established relationship with DLA as a critical pharmaceutical supplier for federal medical procurement needs. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies to military healthcare systems and other federal agencies worldwide. AmerisourceBergen's consistent receipt of competitively awarded, non-set-aside contracts across multiple therapeutic domains demonstrates its capability to fulfill specialized federal medical supply requirements, including specialized pharmaceuticals such as the antibiotic Difici delivered under this order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 8/5/25 |